|Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis|
DA Palma, S Senan, C Oberije, J Belderbos, NR De Dios, JD Bradley, ...
International Journal of Radiation Oncology* Biology* Physics 87 (4), 690-696, 2013
|Imaging cellular proliferation during chemo-radiotherapy: A pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non–small-cell lung cancer|
S Everitt, RJ Hicks, D Ball, T Kron, M Schneider-Kolsky, T Walter, D Binns, ...
International Journal of Radiation Oncology* Biology* Physics 75 (4), 1098-1104, 2009
|Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging|
JA Hayman, JW Callahan, A Herschtal, S Everitt, DS Binns, RJ Hicks, ...
International Journal of Radiation Oncology* Biology* Physics 79 (3), 847-852, 2011
|High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose‐positron emission tomography/computed tomography scans in radical …|
S Everitt, A Herschtal, J Callahan, N Plumridge, D Ball, T Kron, ...
Cancer 116 (21), 5030-5037, 2010
|Reproducibility of “intelligent” contouring of gross tumor volume in non–small-cell lung cancer on PET/CT images using a standardized visual method|
M Bayne, RJ Hicks, S Everitt, N Fimmell, D Ball, J Reynolds, E Lau, ...
International Journal of Radiation Oncology* Biology* Physics 77 (4), 1151-1157, 2010
|Differential 18F-FDG and 18F-FLT uptake on serial PET/CT imaging before and during definitive chemoradiation for non–small cell lung cancer|
SJ Everitt, DL Ball, RJ Hicks, J Callahan, N Plumridge, M Collins, ...
Journal of Nuclear Medicine 55 (7), 1069-1074, 2014
|The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective …|
MP Mac Manus, S Everitt, M Bayne, D Ball, N Plumridge, D Binns, ...
Radiotherapy and Oncology 106 (3), 292-298, 2013
|The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer|
S Everitt, N Plumridge, A Herschtal, M Bressel, D Ball, J Callahan, T Kron, ...
Radiotherapy and Oncology 106 (3), 288-291, 2013
|Distribution atlas of proliferating bone marrow in non-small cell lung cancer patients measured by FLT-PET/CT imaging, with potential applicability in radiation therapy planning|
BA Campbell, J Callahan, M Bressel, N Simoens, S Everitt, MS Hofman, ...
International Journal of Radiation Oncology* Biology* Physics 92 (5), 1035-1043, 2015
|Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes|
J Callahan, T Kron, S Siva, N Simoens, A Edgar, S Everitt, ME Schneider, ...
Radiation oncology 9 (1), 1-8, 2014
|Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by 18F-FLT PET/CT in Patients with Locally Advanced Non–Small Cell …|
A Leimgruber, A Möller, SJ Everitt, M Chabrot, DL Ball, B Solomon, ...
Journal of Nuclear Medicine 55 (7), 1075-1080, 2014
|Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non‐small‐cell lung cancer|
M Macmanus, I D’Costa, S Everitt, J Andrews, T Ackerly, D Binns, E Lau, ...
Australasian radiology 51 (4), 386-393, 2007
|Prospective study of serial imaging comparing fluorodeoxyglucose positron emission tomography (PET) and fluorothymidine PET during radical chemoradiation for non-small cell …|
S Everitt, D Ball, RJ Hicks, J Callahan, N Plumridge, J Trinh, A Herschtal, ...
International Journal of Radiation Oncology* Biology* Physics 99 (4), 947-955, 2017
|Role of PET-CT in the optimization of thoracic radiotherapy|
M Mac Manus, RJ Hicks, S Everitt
Journal of Thoracic Oncology 1 (1), 81-84, 2006
|Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol|
T Konert, WV Vogel, S Everitt, MP MacManus, D Thorwarth, E Fidarova, ...
Radiotherapy and Oncology 121 (1), 39-45, 2016
|Spleen volume variation in patients with locally advanced non-small cell lung cancer receiving platinum-based chemo-radiotherapy|
SW Wen, SJ Everitt, J Bedő, M Chabrot, DL Ball, B Solomon, ...
PloS one 10 (11), e0142608, 2015
|What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or …|
GA Turgeon, A Iravani, T Akhurst, A Beaulieu, JW Callahan, M Bressel, ...
Journal of Nuclear Medicine 60 (3), 328-334, 2019
|Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization|
M MacManus, S Everitt, T Schimek-Jasch, XA Li, U Nestle
Translational lung cancer research 6 (6), 670, 2017
|Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer|
S Everitt, M Duffy, M Bressel, B McInnes, C Russell, T Sevitt, D Ball
Radiation Oncology 11 (1), 1-7, 2016
|Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?|
T Konert, S Everitt, MD La Fontaine, JB van de Kamer, MP MacManus, ...
PloS one 15 (2), e0228793, 2020